Target intelligence / Profile preview

Ribosomal protein L7 pseudogene 57 (RPL7P57)

Target
RPL7P57
Molecular classification
Other (Processed pseudogene)
01

Overview

Ribosomal protein L7 pseudogene 57 (RPL7P57) is a processed pseudogene resulting from duplication or retrotransposition of the RPL7 gene, which encodes a component of the large (60S) ribosomal subunit involved in protein synthesis in the cell[7][2][10]. Pseudogenes such as RPL7P57 typically do not encode functional protein products, and there is no evidence that this pseudogene has therapeutic, biomarker, or disease-associated activity. It mainly exists as a nonfunctional genomic element and is not considered a drug target or receptor[7][2]. RPL7P57 is a pseudogene, not a functional receptor, enzyme, or target molecule. It is a noncoding DNA sequence derived from a protein-coding gene (RPL7)[2][7][10]. There is no evidence that RPL7P57 itself is involved in disease, drug response, or other biological processes that would qualify it as a therapeutic target. The parental gene, RPL7, encodes a ribosomal protein involved in ribosome structure and function, but pseudogenes (such as RPL7P57) generally lack such activities and are not expressed as functional proteins[1][4]. Large numbers of ribosomal protein pseudogenes are common throughout the human genome and are not unique to RPL7[10].

Other names
RPL7_22_1777RPL7P57

Beyond the preview

Go deeper on Ribosomal protein L7 pseudogene 57 (RPL7P57).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L7 pseudogene 57 (RPL7P57).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call